India's Nifty holds key support despite geopolitical risks
India's benchmark index is weathering geopolitical pressures and inflation fears as strong corporate earnings anchor technical support levels, prompting a shift toward stock-specific strategies.
The Nifty 50 rose 0.70% to approach 24,250 in morning trade on Friday, 17 July, holding steady a day after closing flat. The benchmark is navigating immediate headwinds from an escalating US-Iran conflict, elevated crude oil prices, and mounting inflation fears.
Strong first-quarter earnings are currently limiting the downside, keeping the index above a critical technical floor. Ajit Mishra, SVP of Research at Religare Broking, noted the Nifty is holding at 24,050, where the 20-day exponential moving average coincides with a rising trendline.
"On an immediate basis, a break below 24,050 could drag the index towards the crucial 23,800 level. On the upside, a decisive breakout above 24,200-24,300 may pave the way for an up move towards 24,500–24,600," said Mishra. He recommends that investors adopt a stock-specific approach while maintaining disciplined risk and position management.
Technical breakouts drive selections
Within this framework, Mishra highlights BHEL as a short-term opportunity after the stock resumed its uptrend above its 50-day exponential moving average. The build-up follows a sharp rally from April 2026 and a breakout from a bullish flag pattern backed by positive price-volume action. "With the overall structure remaining positive, one may consider accumulating the stock within the recommended price range," said Mishra.
Depository participant CDSL is also demonstrating a constructive setup through a symmetrical triangle pattern characterized by higher highs and higher lows. "A decisive breakout above the pattern's upper trendline is likely to trigger fresh buying interest and accelerate the next leg of the rally," Mishra noted. "Considering the favorable technical setup, investors may consider accumulating the stock within the recommended price range."
Broader sectoral trends are informing the current strategy, particularly sustained buying in pharmaceuticals and healthcare. Divi's Laboratories has registered a volume-backed breakout after consolidating for nearly a year, successfully reclaiming its record high to resume its long-term uptrend. "Given the favourable technical structure and continued sectoral strength, traders may consider accumulating the stock on a cash delivery basis," Mishra said.
